Hence, knockdown of Par2 (Figure 3A) or blocking of PAR2-mediated cell signaling via the Pc(4-4)compound (Figure 6C) both resulted in significant inhibition of ovarian cancer growth and peritoneal dissemination. Here, F2RL1 is linked to ovarian carcinoma.